HHS Stock Analysis: Buy, Sell, or Hold?
$3.03
-0.09 (-2.88%)
▼
BUY
HIGH Confidence
Last Updated: January 30, 2026
Earnings: Mar 16, 2026
Get Alerted When HHS Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: HHS shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: HHS shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$4.35
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$2.70
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 2.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: HHS is currently trading at $3.03, which is considered fair relative to its 30-day fair value range of $2.94 to $3.19. The stock's valuation (Forward PE: 2.9) is in line with its historical norms (2.9). Remarkably, the market is currently pricing in an annual earnings decline of 0.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, HHS is in a strong downtrend. Immediate support is located at $2.92, while resistance sits at $3.33.
Market Sentiment: HHS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.50 (+460.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, HHS is in a strong downtrend. Immediate support is located at $2.92, while resistance sits at $3.33.
Market Sentiment: HHS has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.50 (+460.9%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$2.94 -
$3.19
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
83.3%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 460.9% below Wall St target ($17.50)
Fair Price Analysis
30-Day Fair Range
$2.94 -
$3.19
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$2.92
Resistance Level
$3.33
Current Trend
Strong Downtrend
Fundamental Context
Forward P/E (Next Year Est.)
2.92
Wall Street Target
$17.50
(+460.9%)
Revenue Growth (YoY)
-17.0%
Earnings Growth (YoY)
-90.3%
Profit Margin
-3.3%
Valuation Discount vs History
-0.3% cheaper
PE vs Historical
2.9 vs 2.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.3%
(market-implied from PE analysis)
1-Year Target
$3.11
(0%)
2-Year Target
$3.10
(-1%)
3-Year Target
$3.09
(-1%)
3-Yr Target (if PE normalizes)
(PE: 3→3)
PE COMPRESSION
$3.08
(-1%)
Earnings growth offset by PE compression
Last updated: January 30, 2026 11:05 PM ET
Data refreshes hourly during market hours. Next update: 12:05 AM
Data refreshes hourly during market hours. Next update: 12:05 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is HHS showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Conglomerates Stocks
Top-rated stocks in Conglomerates by analyst ratings.
Advanced HHS Option Strategies
Professional options setups generated by AI based on today's HHS price and gamma walls.